Cerenome files Sept 30 investor deck; exhibit has no financials, pipeline data or guidance

PLUS THERAPEUTICS, INC.

Investor presentation dated September 30, 2026 was filed as Exhibit 99.1, but the appended text contains only a title page ('Corporate Presentation (NASDAQ:CNSY)') with no numbers or outlook.
No earnings, revenue, cash balance, trial data or guidance is disclosed anywhere in the 8-K or its exhibit, so no investment conclusions can be drawn from this filing.
Registrant is Cerenome, Inc., formerly Plus Therapeutics, Inc., with common stock on the Nasdaq Capital Market under symbol CNSY and offices at 6420 Levit Green Boulevard, Suite 310, Houston, Texas.
Report signed October 2, 2026 by President and Chief Executive Officer Marc H. Hedrick, M.D.; Item 8.01 lists only the presentation update as the event.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.